Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.6.3 was added, replacing the previous v3.6.2. This reflects a minor page update that does not alter study details or functionality.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous Revision: v3.6.0. This reflects a minor update to the page’s release version without altering the study details.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study page now states it is no longer recruiting participants and adds sections on reading the study record, common questions, and how to join. Formatting for the Intervention/Treatment heading was adjusted and the revision note updated to v3.6.0.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision was recorded.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision line was updated from Revision: v3.5.3 to Revision: v3.5.4, indicating an administrative update to the page metadata.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s platform/version indicator has been updated from Revision: v3.5.2 to Revision: v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.